Xencor Inc (XNCR)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $2.78B
Last updated: Nov 17, 2026 at 11:06 AM ET
Xencor Inc (XNCR) Financials: Revenue, Profit and Cash Flow
Xencor reported revenue of $125.58M for the fiscal year ended Dec 31, 2025, up 13.7% from the year before. That year, net income was -$92.14M with a net margin of -73.4%, operating cash flow was -$135.12M and free cash flow was -$138.27M. The quarter ended Sep 30, 2026 had revenue of $116.52M and net income of $39.44M.
Revenue and Margins
The net margin was -73.4% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $109.02M, a compound annual rate of 1.6%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $125.58M | +13.7% | 100.0% | -141.4% | -73.4% |
| Dec 2024 | $110.49M | -36.7% | 100.0% | -161.5% | -214.1% |
| Dec 2023 | $174.62M | +6.1% | 100.0% | -75.8% | -76.3% |
| Dec 2022 | $164.58M | -40.2% | 100.0% | -50.1% | -33.5% |
| Dec 2021 | $275.11M | +124.2% | 100.0% | 15.9% | 30.0% |
| Dec 2020 | $122.69M | -21.7% | 100.0% | -62.6% | -56.5% |
| Dec 2019 | $156.70M | +285.9% | 100.0% | 8.8% | 17.2% |
| Dec 2018 | $40.60M | -12.1% | 100.0% | -195.5% | -173.4% |
| Dec 2017 | $46.20M | -57.6% | 100.0% | -93.3% | -83.3% |
| Dec 2016 | $109.02M | N/A | 100.0% | 40.4% | 41.4% |
Income Statement
In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, net income turned positive after a loss in the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $125.58M | $110.49M | $174.62M | $164.58M | $275.11M | $122.69M | $156.70M | $40.60M | $46.20M | $109.02M |
| Gross profit | $125.58M | $110.49M | $174.62M | $164.58M | $275.11M | $122.69M | $156.70M | $40.60M | $46.20M | $109.02M |
| Research and development | $239.43M | $227.69M | $253.60M | $199.56M | $192.51M | $169.80M | $118.59M | $97.50M | $71.77M | $51.87M |
| Operating income | -$177.50M | -$178.41M | -$132.36M | -$82.47M | $43.77M | -$76.80M | $13.82M | -$79.37M | -$43.12M | $44.04M |
| Net income | -$92.14M | -$236.54M | -$133.30M | -$55.18M | $82.63M | -$69.33M | $26.88M | -$70.41M | -$38.49M | $45.13M |
| EBITDA | -$78.20M | N/A | N/A | -$50.40M | $92.43M | -$71.08M | N/A | -$76.64M | -$38.26M | $47.55M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $116.52M | $51.22M | $4.52M | $28.24M | $21.00M | $43.61M | $32.73M | $52.79M | $17.80M | $23.91M | $16.00M | $50.97M |
| Gross profit | $116.52M | $51.22M | $4.52M | $28.24M | $21.00M | $43.61M | $32.73M | $52.79M | $17.80M | $23.91M | $16.00M | $50.97M |
| Operating income | $22.86M | -$37.07M | -$77.86M | -$53.63M | -$47.52M | -$33.17M | -$43.18M | -$13.18M | -$55.20M | -$55.37M | -$54.66M | -$27.35M |
| Net income | $39.44M | -$21.73M | -$128.92M | -$6.65M | -$6.03M | -$30.82M | -$48.63M | -$46.20M | -$47.44M | -$68.78M | -$74.12M | -$26.31M |
Balance Sheet
As of Dec 2025, total debt of $119.75M exceeded cash and equivalents by $65.68M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $875.50M | $951.95M | $965.13M | $846.27M | $537.75M | $703.24M | $670.25M | $576.73M | $390.20M | $428.56M |
| Current assets | $599.82M | $577.60M | $635.60M | $675.34M | $424.37M | $637.67M | $558.40M | $315.73M | $230.88M | $141.65M |
| Cash and equivalents | $54.07M | $40.88M | $53.79M | $53.94M | $143.48M | $163.54M | $50.31M | $26.25M | $16.53M | $14.53M |
| Total liabilities | $239.91M | $277.92M | $303.05M | $118.77M | $104.71M | $130.80M | $77.05M | $55.05M | $73.74M | $114.61M |
| Short-term debt | $43.27M | $48.45M | $27.71M | $0 | $33.97M | $1.89M | $2.17M | $9.66M | $5.48M | $6.69M |
| Long-term debt | $76.48M | $115.16M | $161.77M | $0 | N/A | N/A | N/A | N/A | $0 | $0 |
| Shareholder equity | $635.59M | $677.61M | $661.75M | $727.50M | $733.50M | $572.44M | $593.20M | $521.68M | $316.46M | $313.95M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $770.50M | $724.96M | $736.85M | $875.50M | $868.81M | $879.42M | $904.69M | $951.95M | $999.90M | $840.62M | $896.85M | $965.13M |
| Total liabilities | $210.07M | $221.73M | $221.21M | $239.91M | $243.50M | $259.07M | $264.81M | $277.92M | $293.98M | $291.90M | $297.12M | $303.05M |
| Cash and equivalents | $59.62M | $44.66M | $14.17M | $54.07M | $28.29M | $44.44M | $39.67M | $40.88M | $29.03M | $30.77M | $31.03M | $53.79M |
| Shareholder equity | $560.43M | $503.23M | $515.63M | $635.59M | $625.32M | $620.35M | $639.87M | $677.61M | $708.86M | $550.50M | $600.07M | $661.75M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$135.12M | -$202.19M | -$77.93M | $24.48M | -$16.85M | -$5.00M | $64.37M | -$79.76M | -$33.60M | $95.24M |
| Capital expenditures | $3.15M | $6.10M | $18.45M | $38.49M | $13.30M | $10.54M | $7.35M | $7.21M | $5.31M | $1.51M |
| Free cash flow | -$138.27M | -$208.28M | -$96.37M | -$14.01M | -$30.15M | -$15.54M | $57.02M | -$86.97M | -$38.91M | $93.73M |
| Share repurchases | $0 | $12.08M | $0 | $0 | N/A | N/A | N/A | $14.74M | N/A | $7.28M |
| Investing cash flow | $139.99M | -$7.87M | -$111.06M | -$119.72M | -$46.25M | $100.19M | -$50.97M | -$164.77M | $31.86M | -$214.27M |
| Financing cash flow | $8.23M | $197.15M | $189.22M | $5.70M | $43.04M | $18.04M | $10.66M | $254.24M | $3.73M | $120.97M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $2.64M | -$55.66M | -$67.63M | -$51.71M | -$30.82M | -$36.37M | -$16.22M | -$49.84M | -$28.14M | -$67.35M | -$56.86M | $18.17M |
| Capital expenditures | $1.80M | $538.00K | $610.00K | $1.14M | $183.00K | $383.00K | $1.44M | $1.66M | $1.27M | $3.03M | $132.00K | $980.00K |
| Free cash flow | $838.00K | -$56.20M | -$68.24M | -$52.85M | -$31.00M | -$36.75M | -$17.66M | -$51.50M | -$29.42M | -$70.38M | -$56.99M | $17.19M |
Frequently Asked Questions About XNCR
What is Xencor's annual revenue?
Xencor reported revenue of $125.58M for the fiscal year ended Dec 31, 2025.
How fast is Xencor's revenue growing?
Revenue was up 13.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -8.6%.
Is Xencor profitable?
No. Xencor reported net income of -$92.14M for the fiscal year ended Dec 31, 2025, with a net margin of -73.4%.
How much free cash flow does XNCR generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of -$135.12M minus capital expenditures of $3.15M produced free cash flow of -$138.27M.
How much debt does Xencor have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $76.48M, short-term debt of $43.27M and cash and equivalents of $54.07M.
XNCR pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors